Results 241 to 250 of about 6,727 (271)
Some of the next articles are maybe not open access.
Journal of Drug Delivery and Therapeutics
Stroke is a sudden cerebral root neurologic collapse, a major cause for global morbidity and death, necessitates the use of neuroprotectants to prevent further damage to ischemic decline.
Karthick Murugesan +5 more
semanticscholar +1 more source
Stroke is a sudden cerebral root neurologic collapse, a major cause for global morbidity and death, necessitates the use of neuroprotectants to prevent further damage to ischemic decline.
Karthick Murugesan +5 more
semanticscholar +1 more source
[Reaction times during citicoline treatment].
La Clinica terapeutica, 2002The effects of Citicoline were investigated in 40 patients with pathological cerebral involution of atrophic origin. The dose was 1000 mg/die by parenteral injection for 4 weeks; 20 patients, after a wash-out of a week, received another cycle of Citicoline at the same doses for other 4 weeks.
R, Bettini, M, Gorini
openaire +1 more source
Biomedical & Pharmacology Journal
The number of neurons in the sensory ganglion decreases after a peripheral nerve injury (PNI) caused by oral trauma or maxillofacial surgery, resulting in an incomplete nerve regeneration process.
Rina Susilowati +4 more
semanticscholar +1 more source
The number of neurons in the sensory ganglion decreases after a peripheral nerve injury (PNI) caused by oral trauma or maxillofacial surgery, resulting in an incomplete nerve regeneration process.
Rina Susilowati +4 more
semanticscholar +1 more source
Citicoline. Ferrer Internacional.
Current opinion in investigational drugs (London, England : 2000), 2002Citicoline was originally developed and launched by Ferrer for the treatment of stroke, and is now also being investigated for the potential treatment of Alzheimer's disease (AD). In the US, the compound is being developed by Interneuron for the treatment of stroke.
openaire +1 more source
Use of Citicoline in Attention-Deficit/Hyperactivity Disorder: A Pilot Study
Clinical neuropharmacologyObjectives Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurobehavioral disorder in school-aged children. Although there are several drug treatment options, some patients do not have adequate therapeutic responses to conventional ...
Isabel Barros Hübner +3 more
semanticscholar +1 more source
Journal of Experimental and Clinical Anatomy
BACKGROUND AND AIM: The study evaluated the histomorphology and histomorphometry of the left ventricle of Wistar rats following middle cerebral artery occlusion (MCAO)-induced cerebral hypoperfusion.
I. Benson +8 more
semanticscholar +1 more source
BACKGROUND AND AIM: The study evaluated the histomorphology and histomorphometry of the left ventricle of Wistar rats following middle cerebral artery occlusion (MCAO)-induced cerebral hypoperfusion.
I. Benson +8 more
semanticscholar +1 more source
African Journal of Biomedical Research
A new HPLC method was developed and validated for the separation and analysis of Citicoline and Piracitam degradation products were characterized using LC-MS/MS. The chromatographic method was optimized using specimens generated by stress degradation. On
K. Ramesh +3 more
semanticscholar +1 more source
A new HPLC method was developed and validated for the separation and analysis of Citicoline and Piracitam degradation products were characterized using LC-MS/MS. The chromatographic method was optimized using specimens generated by stress degradation. On
K. Ramesh +3 more
semanticscholar +1 more source
Oral Citicoline and Diabetic Retinopathy: Effects on Macular Ganglion Cell Layer Thickness
Unram Medical JournalDiabetic retinopathy (DR) is the main cause of blindness at a productive age, especially in developing countries including Indonesia. Damage to the retinal neural unit occurs to precede vascular disorders and inflammation. Citicoline has been used widely
Monalisa Nasrul +4 more
semanticscholar +1 more source